HT
ANIK icon

HAP Trading’s Anika Therapeutics ANIK Stock Holding History

HAP Trading’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-212,500
Closed -$186K – 2333
2021
Q1 		$186K Sell
212,500
-100
-0% -$3.79K 0.01% 788
2020
Q4 		$819K Sell
212,600
-32,700
-13% -$1.24M 0.02% 476
2020
Q3 		$564K Buy
245,300
+47,800
+24% +$1.73M 0.03% 382
2020
Q2 		$1.15M Buy
+197,500
New +$6.51M 0.06% 252
2015
Q2 		– Sell
-15,200
Closed -$8K – 978
2015
Q1 		$8K Buy
+15,200
New +$614K ﹤0.01% 811

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HAP Trading's ANIK Position: Q4 2018 in Review

HAP Trading sold out of Anika Therapeutics (ANIK) in Q4 2018, closing a stake of 14,574 shares — an estimated $615K sold.

HAP Trading first reported a position in ANIK in Q3 2018 and held it in 1 quarter. The position peaked at $615K in Q3 2018. 162 funds tracked by Wall St. Rank hold ANIK as of Q4 2018.

  • HAP Trading reported no remaining Anika Therapeutics position as of Q4 2018 after selling out during the quarter.
  • HAP Trading sold 14,574 Anika Therapeutics shares in Q4 2018, an estimated $615K.
  • HAP Trading first reported a position in Anika Therapeutics in Q3 2018 and held it in 1 quarter.
  • HAP Trading's Anika Therapeutics position peaked at $615K in Q3 2018.
  • 162 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2018.

Based on HAP Trading's 13F filing for Q4 2018, filed 12 Feb 2019.